Vitiligo can affect the skin on any part of the body, including the hair and the inside of the mouth. Vitiligo affects about 1% of the world’s population and usually appears before age 30.

Vitiligo typically begins on the hands, forearm, feet and face. But, it can develop on any part of the body, including the mucous membranes (moist lining of the mouth, nose, genitals and rectal area), ...

Vitiligo is believed to be an autoimmune condition where the body attacks its own healthy melanin-producing skin cells by mistake. It may be hereditary or triggered by a particular event like ...

People with vitiligo often need to use many medicines every day to help regain pigment in their skin and reduce other side effects. Some people may use light therapy, pills, or surgery to help ...

In June last year, Egyptian singer and composer Ramy Gamal made headlines when he became the first celebrity to speak candidly about suffering and living with vitiligo. He chronicled the stages of ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

"Notably, the study found that the thresholds for meaningful change are lower than those typically established in clinical ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...

Yvette Fielding, who was Blue Peter's youngest ever presenter at just 17, has battled with the skin condition vitiligo for most of her life. Yvette, 34, who lives in Cheshire with her husband Karl ...

Model Winnie Harlow felt isolated when first diagnosed with vitiligo but now says it's one of her "greatest gifts" A controversial new treatment for a condition called vitiligo that can restore ...

Incyte is preparing to take an oral JAK inhibitor into phase 3 trials for the skin depigmentation disease vitiligo, after reporting mid-stage data showing efficacy in patients with facial and full ...

VYN201 Phase 2b vitiligo trial exceeds enrollment target; Expected to be fully enrolled in December 2024 with top-line results on track for ...